MASLD, diabetes and PMOS across the female life stages

Elisabet Stener-Victorin, Sofia Carlsson, Hannes Hagström, Nayere Taebnia · 2026

Read MASLD, diabetes and PMOS across the female life stages by Elisabet Stener-Victorin, Sofia Carlsson, Hannes Hagström, Nayere Taebnia (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13627221.txt.

Description

Elisabet Stener-Victorin and colleagues review how fatty liver disease, type 2 diabetes, and polycystic ovary syndrome intertwine in women. Fatty liver affects about 38 percent of adults and diabetes about 11 percent, while polycystic ovary syndrome, here called PMOS, affects 10 to 13 percent of reproductive-age women. Their 2026 narrative review links the three through hormones, insulin resistance, and inflammation.

Excess androgens drive liver fat genes, switch on scarring cells, and suppress a binding protein, building a scar-prone, fat-toxic liver. Shared pathways span fat-tissue failure, faulty fat signals, and weak mitochondria, with adolescence, pregnancy, and menopause as vulnerable windows. Stener-Victorin and colleagues urge life-stage screening and early action.

Catalog record

CREATORElisabet Stener-Victorin, Sofia Carlsson, Hannes Hagström, Nayere Taebnia
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE47 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13627221

Browse the full library · About the Tower of Babel